TNFSF10 and neoplasm: Numerous TRAIL resistant tumour cell lines were reported to be sensitised to TRAIL by combined treatments with chemotherapeutic agents, cycloheximide (CHX), IFN-γ or irradiation by diverse cell-type specific mechanisms [17,18].